AYTU BioPharma, Inc. Common Stock (AYTU) is a publicly traded Healthcare sector company. As of November 10, 2026, AYTU trades at $1.81 with a market cap of $19.45M and a P/E ratio of -1.80. AYTU moved +0.00% today. Year to date, AYTU is -34.40%; over the trailing twelve months it is -13.06%. Its 52-week range spans $0.95 to $3.07. Analyst consensus is strong buy with an average price target of $9.67. Rallies surfaces AYTU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AYTU shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.81 |
| Market Cap | $19.45M |
| P/E Ratio | -1.80 |
| EPS | $-1.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.07 |
| 52-Week Low | $0.95 |
| Volume | 26.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $57.57M |
| Net Income | $-14.25M |
| Gross Margin | 63.95% |
3 analysts cover AYTU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.67.